Um, how do these address patient-centered goals? How does each guideline inform about lo- local practice? And, uh, what are the most important recommendations for each guideline? So, um, a quick run through, uh, these guidelines, and maybe again, let's start with Niels.

Yeah.

I can say a few words about, uh, international consensus, uh, guidelines, uh, published in two thousand and twenty-one.

Uh, and I think a main thing of these regarding these guidelines is a focus on active treatment, that we should be ambitious in treatment.

That comes also in, of course, in the later guidelines.

But especially in the update two thousand twenty-one, I think it was a stronger focus on, uh, ambitious aims, uh, and also to define the measurements for improvement using MG-ADL, QMG.

That's both patient-reported outcomes and, uh, uh, measured outcomes by the neurologist, including also quality of life.

So Nils, how would the Nordic guidelines deal here?